Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by Hoosier Cancer Research Network
Sponsor:
Collaborators:
Vera Bradley Foundation for Breast Cancer
Walther Cancer Institute
Strategic Research Initiative Grant through IUSCC
Information provided by (Responsible Party):
Hoosier Cancer Research Network
ClinicalTrials.gov Identifier:
NCT02101385
First received: March 21, 2014
Last updated: October 20, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)